X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A clinically relevant heterozygous ATR mutation sensitizes colorectal cancer cells to replication stress.

Tom Egger | Benoît Bordignon | Arnaud Coquelle
Scientific reports | 2022

Colorectal cancer (CRC) ranks third among the most frequent malignancies and represents the second most common cause of cancer-related deaths worldwide. By interfering with the DNA replication process of cancer cells, several chemotherapeutic molecules used in CRC therapy induce replication stress (RS). At the cellular level, this stress is managed by the ATR-CHK1 pathway, which activates the replication checkpoint. In recent years, the therapeutic value of targeting this pathway has been demonstrated. Moreover, MSI + (microsatellite instability) tumors frequently harbor a nonsense, heterozygous mutation in the ATR gene. Using isogenic HCT116 clones, we showed that this mutation of ATR sensitizes the cells to several drugs, including SN-38 (topoisomerase I inhibitor) and VE-822 (ATR inhibitor) and exacerbates their synergistic effects. We showed that this mutation bottlenecks the replication checkpoint leading to extensive DNA damage. The combination of VE-822 and SN-38 induces an exhaustion of RPA and a subsequent replication catastrophe. Surviving cells complete replication and accumulate in G2 in a DNA-PK-dependent manner, protecting them from cell death. Together, our results suggest that RPA and DNA-PK represent promising therapeutic targets to optimize the inhibition of the ATR-CHK1 pathway in oncology. Ultimately, ATR frameshift mutations found in patients may also represent important prognostic factors.

Pubmed ID: 35361811 RIS Download

Research resources used in this publication

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


RPA32/RPA2 antibody [9H8] (antibody)

RRID:AB_302873

This monoclonal targets RPA32/RPA2

View all literature mentions

GAPDH antibody [6C5] (antibody)

RRID:AB_2107448

This monoclonal targets GAPDH antibody [6C5]

View all literature mentions

Goat Anti-Rat IgG-FITC (antibody)

RRID:AB_2795818

This unknown targets IgG

View all literature mentions

Goat Anti-Rabbit IgG(H+L)-HRP (antibody)

RRID:AB_2795980

This unknown targets IgG(H+L)

View all literature mentions

Goat Anti-Mouse IgG, Human ads-HRP (antibody)

RRID:AB_2619742

This polyclonal targets mouse IgG

View all literature mentions

KAP1 (phospho S143) antibody (antibody)

RRID:AB_11157160

This polyclonal targets KAP1 (phospho S143) antibody

View all literature mentions

ATM (D2E2) Rabbit mAb (antibody)

RRID:AB_2062659

This monoclonal targets ATM (D2E2) Rabbit mAb

View all literature mentions

Anti-53BP1, phospho (Ser1778) Antibody, Unconjugated (antibody)

RRID:AB_490917

This unknown targets 53BP1, phospho (Ser1778)

View all literature mentions

beta Tubulin antibody - Loading Control (antibody)

RRID:AB_727043

This polyclonal targets beta Tubulin antibody - Loading Control

View all literature mentions

Phospho RPA32 (S4/S8) Antibody (antibody)

RRID:AB_210547

This unknown targets Phospho-RPA32 (Ser4, Ser8)

View all literature mentions

Chk1 (2G1D5) Mouse mAb (antibody)

RRID:AB_2080320

This monoclonal targets Chek1

View all literature mentions

Phospho-Chk1 (Ser345) (133D3) Rabbit mAb (antibody)

RRID:AB_331212

This monoclonal targets Chk1, phospho (Ser345)

View all literature mentions

ATR Antibody (antibody)

RRID:AB_2227860

This polyclonal targets ATR

View all literature mentions

ATR (phospho Thr1989) antibody (antibody)

RRID:AB_2687562

This polyclonal targets ATR (phospho Thr1989)

View all literature mentions

DNA PKcs (phospho S2056) antibody - ChIP Grade (antibody)

RRID:AB_869495

This polyclonal targets Human DNA PKcs (phospho S2056)

View all literature mentions

BrdU (antibody)

RRID:AB_609568

This unknown targets

View all literature mentions

Chk2 Antibody (antibody)

RRID:AB_2080793

This polyclonal targets Chek2

View all literature mentions

Phospho-Chk2 (Ser19) Antibody (antibody)

RRID:AB_330057

This unknown targets Chk2, phospho (Ser19)

View all literature mentions

Phospho-Histone H2A.X (Ser139) (20E3) Rabbit mAb (antibody)

RRID:AB_2118009

This monoclonal targets Histone H2A.X, phospho (Ser139)

View all literature mentions

Cleaved Caspase-3 (Asp175) Antibody (antibody)

RRID:AB_2341188

This polyclonal targets Cleaved Caspase-3 (Asp175)

View all literature mentions

HCT 116 (cell line)

RRID:CVCL_0291

Cell line HCT 116 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions